Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-11-04

Clinical Trial Update: Impact of Tecfidera on Gut Microbiota

View source ↗

Summary

This document reports an update on a clinical trial investigating the effect of Tecfidera (dimethyl fumarate) on the gut microbiota in people with Multiple Scle…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tecfidera (dimethyl fumarate)

Snippet

Sponsor: Virginia Simnad | Conditions: Multiple Sclerosis | Status: UNKNOWN